Physician profile
Gregory Alan Joice
NPI 1376980037
$61,284.11
in general payments reported to CMS, 2019-2025
19 companies · $6,110 in 2025
The $6,110 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51K · 2021: $1,620 · 2022: $647 · 2023: $570 · 2024: $1,732 · 2025: $6,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $3,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $3,911.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $57,449.15 | 2020-2025 | Ams 700, General - Erectile Dysfunction, General - Male Sui |
| Coloplast Corp | $2,525.37 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $441.52 | 2023-2025 | Gemtesa |
| Olympus America INC. | $144.71 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $144.11 | 2021-2023 | Xiaflex, Edex, Aveed |
| Hollister Incorporated | $92.04 | 2023-2024 | Infyna Chic, Onli, Vapro |
| Baxter Healthcare | $85.34 | 2024 | Perclot |
| Progenics Pharmaceuticals, INC. | $65.60 | 2024 | |
| Rigicon,INC. | $54.85 | 2023-2024 | Rigi10 Malleable Penile Prosthesis, Rigi10 Malleable Penile Prosthesis |
| Urogen Pharma, INC. | $54.16 | 2022-2023 | Jelmyto |
| Innovation Technologies INC | $43.92 | 2023 | Irrisept |
| Antares Pharma, INC. | $42.87 | 2022 | |
| Abc Home Medical Supply, INC. | $40.72 | 2024-2025 | |
| Immunitybio, INC. | $27.32 | 2024 | |
| Ambu INC. | $25.45 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $24.32 | 2024 | Xiaflex |
| Teleflex LLC | $15.78 | 2025 | Barrigel |
| Kerecis Limited | $6.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Joice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.